Medicaid Program; Final FY 2018, Final FY 2019, Preliminary FY 2020, and Preliminary FY 2021 Disproportionate Share Hospital Allotments, and Final FY 2018, Final FY 2019, Preliminary FY 2020, and Preliminary FY 2021 Institutions for Mental Diseases Disproportionate Share Hospital Limits, 14858-14888 [2022-05459]
Download as PDF
14858
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
stakeholders relevant to the issues. The
survey format will differ depending on
the project, but may be conducted in
one or more of the following ways, both
in-person and virtually: Individual or
group interviews, individual or group
discussions, or written surveys. The
survey requests information such as
stakeholder understanding of the
particular issue, stakeholder interests in
the particular issue, appropriate
stakeholders, methods of engagement
with the issue, and other similar
information that will allow FMCS to
best create a successful process. A link
to the survey is found here: https://
tags.fmcs.gov/4DAction/FC/
DoAsynchTop?Fedreg*UPPJ*919/10300.
To log in, go to: https://tags.fmcs.gov/,
use user name ‘‘Fedreg’’ and password
‘‘UPPJ.’’ The collection of such
information is critical for ensuring the
appropriate process, stakeholders, and
stakeholder input in the process. No
other collections are being conducted
that would provide this information to
FMCS.
Burden: The current total annual
burden estimate is that FMCS will
receive information from approximately
15,000 respondents per year. Interviews
and discussions would be
approximately thirty minutes in
duration. Written surveys would take
approximately ten minutes to complete.
FMCS expects the total burden to not
exceed 2,535 hours per year.
II. Request for Comments
jspears on DSK121TN23PROD with NOTICES1
FMCS solicits comments to:
i. Evaluate whether the proposed
collections of information are necessary
for the proper performance of the
functions of the agency, including
whether the information will have
practical utility.
ii. Enhance the accuracy of the
agency’s estimates of the burden of the
proposed collection of information.
iii. Enhance the quality, utility, and
clarity of the information to be
collected.
iv. Minimize the burden of the
collections of information on those who
are to respond, including the use of
appropriate automated, electronic
collection technologies or other forms of
information technology.
III. The Official Record
The official records are electronic
records.
List of Subjects
Information Collection Requests.
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
Dated: March 11, 2022.
Sarah Cudahy,
Senior Advisor, Federal Mediation and
Conciliation Service.
[FR Doc. 2022–05543 Filed 3–15–22; 8:45 am]
BILLING CODE 6732–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–2436–N]
RIN 0938–ZB62
Medicaid Program; Final FY 2018, Final
FY 2019, Preliminary FY 2020, and
Preliminary FY 2021 Disproportionate
Share Hospital Allotments, and Final
FY 2018, Final FY 2019, Preliminary FY
2020, and Preliminary FY 2021
Institutions for Mental Diseases
Disproportionate Share Hospital Limits
Centers for Medicare &
Medicaid Services (CMS), Department
of Health and Human Services (HHS).
ACTION: Notice.
AGENCY:
This notice announces the
final Federal share (FS) disproportionate
share hospital (DSH) allotments for
Federal fiscal year (FY) 2018 and FY
2019, and the preliminary FS DSH
allotments for FY 2020 and FY 2021.
This notice also announces the final FY
2018 and FY 2019 and the preliminary
FY 2020 and FY 2021 limitations on
aggregate DSH payments that States may
make to institutions for mental disease
and other mental health facilities. In
addition, this notice includes
background information describing the
methodology for determining the
amounts of States’ FY DSH allotments.
DATES: The allotments announced in
this notice are effective April 15, 2022.
The final allotments and limitations set
forth in this notice are applicable for the
fiscal years specified.
FOR FURTHER INFORMATION CONTACT:
Stuart Goldstein, (410) 786–0694 and
Richard Cuno, (410) 786–1111.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background
A. Fiscal Year DSH Allotments
A State’s Federal fiscal year (FY)
disproportionate share hospital (DSH)
allotment represents the aggregate limit
on the Federal share (FS) amount of the
State’s DSH payments to DSH hospitals
in the State for the FY. The amount of
such allotment is determined in
accordance with the provisions of
section 1923(f) of the Social Security
PO 00000
Frm 00039
Fmt 4703
Sfmt 4703
Act (the Act), with some State-specific
exceptions as specified in section
1923(f) of the Act. Under such
provisions, in general, a State’s FY DSH
allotment is calculated by increasing the
amount of its DSH allotment for the
preceding FY by the percentage change
in the Consumer Price Index for all
Urban Consumers (CPI–U) for the
previous FY.
The Patient Protection and Affordable
Care Act of 2010 (Pub. L. 111–148), as
amended by the Health Care and
Education Reconciliation Act of 2010
(Pub. L. 111–152) (collectively, the
Affordable Care Act), amended
Medicaid DSH provisions, adding
section 1923(f)(7) of the Act. Section
1923(f)(7) of the Act would have
required reductions to States’ FY DSH
allotments from FY 2014 through FY
2020, the calculation of which was
described in the Disproportionate Share
Hospital Payment Reduction final rule
published in the September 18, 2013
Federal Register (78 FR 57293).
Subsequent legislation, most recently
the Consolidated Appropriations Act,
2021 (Pub. L. 116–260, enacted
December 27, 2020), delayed the start of
these reductions until FY 2024. The
final rule delineating a revised
methodology for the calculation of DSH
allotment reductions beginning in 2020
(subsequently delayed by further
statutory enactment) was published in
the September 25, 2019 Federal Register
(84 FR 50308).
Because there are no reductions to
DSH allotments for FY 2018 through FY
2023 under section 1923(f)(7) of the Act,
as amended, this notice contains only
the State-specific final FY 2018 and FY
2019 DSH allotments and preliminary
FY 2020 and FY 2021 DSH allotments,
as calculated under the statute without
application of the reductions that would
have been imposed beginning as early as
FY 2014 under prior versions of section
1923(f)(7) of the Act. This notice also
provides information on the calculation
of the FY DSH allotments, the
calculation of the States’ institution for
mental diseases (IMD) DSH limits, and
the amounts of States’ final FY 2018 and
FY 2019 IMD DSH limits and
preliminary FY 2020 and FY 2021 IMD
DSH limits.
B. Determination of Fiscal Year DSH
Allotments
Generally, in accordance with the
methodology specified under section
1923(f)(3) of the Act, a State’s FY DSH
allotment is calculated by increasing the
amount of its DSH allotment for the
preceding FY by the percentage change
in the CPI–U for the previous FY. Also,
in accordance with section 1923(f)(3) of
E:\FR\FM\16MRN1.SGM
16MRN1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES1
the Act, a State’s DSH allotment for a FY
is subject to the limitation that an
increase to a State’s DSH allotment for
a FY cannot result in the DSH allotment
exceeding the greater of the State’s DSH
allotment for the previous FY or 12
percent of the State’s total medical
assistance expenditures for the
allotment year (this is referred to as the
12 percent limit).
Furthermore, under section 1923(h) of
the Act, Federal financial participation
(FFP) for DSH payments to IMDs and
other mental health facilities is limited
to State-specific aggregate amounts.
Under this provision, the aggregate limit
for DSH payments to IMDs and other
mental health facilities is the lesser of
a State’s FY 1995 total computable
(State and FS) IMD and other mental
health facility DSH expenditures
applicable to the State’s FY 1995 DSH
allotment (as reported on the Form
CMS–64 as of January 1, 1997), or the
amount equal to the product of the
State’s current year total computable
DSH allotment and the applicable
percentage specified in section 1923(h)
of the Act.
C. Determination of Fiscal Year DSH
Allotments for FY 2020 and FY 2021
The Families First Coronavirus
Response Act’s (FFCRA) (Pub. L. 116–
127, enacted March 18, 2020) temporary
Federal medical assistance percentage
(FMAP) increase of 6.2 percentage
points went into effect on January 1,
2020 for eligible States, as provided in
section 6008 of the FFCRA. As relevant
to this notice, this FMAP increase
applies to eligible Medicaid
expenditures including DSH payments
for FY 2020 (with the exception of the
1st quarter, from October 1, 2019
through December 31, 2019), and FY
2021, and all States currently are
receiving the temporary FFCRA FMAP
increase. For States that exhaust their
entire DSH allotment, the FFCRA FMAP
increase would effectively reduce the
amount of total computable (TC) DSH
payments that such States could pay to
qualifying providers.
To avoid this reduction in TC DSH
allotments, section 9819 of the
American Rescue Plan Act of 2021
(ARP) (Pub. L. 117–2, enacted March 11,
2021) added section 1923(f)(3)(F) of the
Act, adjusting FS DSH allotments
during periods when and for States
where the temporary 6.2 percentage
point FMAP increase under section
6008 of the FFCRA is in effect. As
directed by the ARP, we are required to
recalculate FS DSH allotments to an
amount that will allow States to make
the same amount of TC DSH payments
as they would have been otherwise able
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
to make in the absence of the FFCRA
FMAP increase.
In accordance with section
1923(f)(3)(B) of the Act, a State’s DSH
allotment for a FY is subject to the
limitation that an increase to a State’s
DSH allotment for a FY cannot result in
the DSH allotment exceeding the greater
of the State’s DSH allotment for the
previous FY or 12 percent of the State’s
total medical assistance expenditures
for the allotment year. Because States
incur medical assistance expenditures
throughout the fiscal year, the
calculations for the 12 percent limit
under section 1923(f)(3)(B)(ii) of the Act
were performed using a prorated FMAP
for FY 2020. To arrive at the stated
limits, we prorated each State’s FY 2020
FMAP rate because the temporary 6.2
percentage point FMAP increase under
section 6008 of the FFCRA does not
apply to the 1st quarter of FY 2020. For
the calculation of the 12 percent limit
for FY 2021, we used the FFCRA FMAP
rate (that is, the otherwise applicable
FMAP rate plus the temporary 6.2
percentage point FFCRA FMAP
increase), because the FFCRA FMAP
rate applies to the entire FY for
qualifying States, and medical
assistance expenditures are made
throughout the year.
Section 1923(f)(3)(F)(i) of the Act
requires us to recalculate the annual
DSH allotment, including the DSH
allotment specified under paragraph
(6)(A)(vi), to ensure that the total DSH
payments (including both Federal and
State shares) that a State may make
related to a fiscal year is equal to the
total DSH payments that the State could
have made for such fiscal year without
such FMAP increase. To meet the
statutory requirement to enable States to
make the same amount of TC DSH
payments as if the FFCRA FMAP
increase were not in effect, we have
used the full (non-prorated) FFCRAincreased FMAP rate in the calculation
of the increased FY 2020 and FY 2021
FS DSH allotments. We used the full
FFCRA-increased FMAP rate rather than
a prorated FMAP rate for the FY 2020
calculation, despite it not being
applicable to the 1st quarter of FY 2020,
to ensure this provision applies to all
States consistent with the statutory
requirement, including a State that
made all DSH payments for FY 2020 in
quarters other than the first fiscal
quarter of that fiscal year.
While States have distinct payment
methodologies that specify when DSH
payments are made to providers, States
may not claim TC DSH payments in
excess of the amount they would have
otherwise been able to claim without
the application of the temporary 6.2
PO 00000
Frm 00040
Fmt 4703
Sfmt 4703
14859
percentage point FFCRA FMAP rate
increase. This is regardless of whether a
portion of unspent FS DSH allotment as
adjusted to account for section
1923(f)(3)(F) of the Act, as added by
section 9819 of the ARP, remains. For
example, if the State made all DSH
payments for FY 2020 during the first
quarter of that FY, then no increase to
the State’s DSH allotment is available
for that year, since the temporary 6.2
percentage point FMAP increase under
section 6008 of the FFCRA was not
available for that quarter and section
1923(f)(3)(F) therefore has no effect. We
will monitor both the FS and TC DSH
allotments to ensure that States do not
exceed statutory authority to claim DSH
payments. Consistent with previous
guidance by CMS during the public
health emergency, States should follow
existing Federal requirements regarding
the applicability of a particular match
rate available for a given quarter,
including reporting prior period
adjustments.
For calculation of the FY 2020 and FY
2021 IMD limits determined under
section 1923(h) of the Act, we used the
ARP-adjusted DSH allotments and the
associated non-prorated FFCRAincreased FMAP rates for FY 2020 and
FY 2021, to reflect the maximum DSH
allotment amount and IMD limit that
might be available to a State, for FY
2020, depending on the State’s timing of
DSH payments.
In general, we determine States’ DSH
allotments for a FY and the IMD DSH
limits for the same FY using the most
recent available estimates of or actual
medical assistance expenditures,
including DSH expenditures and the
most recent available CPI–U data for the
FY in accordance with the methodology
prescribed in the statute. The indicated
estimated or actual expenditures are
obtained from States for each relevant
FY from the most recent available
quarterly Medicaid budget reports
(Form CMS–37) or quarterly Medicaid
expenditure reports (Form CMS–64),
respectively, submitted by the States.
For example, as part of the initial
determination of a State’s FY DSH
allotment (referred to as the preliminary
DSH allotments) that is determined
before the beginning of the FY for which
the DSH allotments and IMD DSH limits
are being determined, we use estimated
expenditures for the FY obtained from
the August submission of the CMS–37
submitted by States prior to the
beginning of the FY; such estimated
expenditures are subject to update and
revision during the FY before actual
expenditure data become available. We
also use the most recent available
estimated CPI–U percentage change that
E:\FR\FM\16MRN1.SGM
16MRN1
14860
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
is available before the beginning of the
FY for determining the States’
preliminary FY DSH allotments; such
estimated CPI–U percentage change is
subject to update and revision during
the FY before the actual CPI–U
percentage change becomes available. In
determining the final DSH allotments
and IMD DSH limits for a FY we use the
actual expenditures for the FY and
actual CPI–U percentage change for the
previous FY.
II. Provisions of the Notice
A. Calculation of the Final FY 2018 and
FY 2019 FS State DSH Allotments and
the Preliminary FY 2020 and FY 2021
FS State DSH Allotments
jspears on DSK121TN23PROD with NOTICES1
1. Final FY 2018 FS State DSH
Allotments
Addendum 1 to this notice provides
the States’ final FY 2018 DSH
allotments determined in accordance
with section 1923(f)(3) of the Act. As
described in the background section, in
general, the DSH allotment for a FY is
calculated by increasing the FY DSH
allotment for the preceding FY by the
CPI–U increase for the previous fiscal
year. For purposes of calculating the
States’ final FY 2018 DSH allotments,
the preceding final fiscal year DSH
allotments (for FY 2017) were published
in the February 11, 2019 Federal
Register (84 FR 3169). For purposes of
calculating the States’ final FY 2018
DSH allotments we are using the actual
Medicaid expenditures for FY 2018.
Finally, for purposes of calculating the
States’ final FY 2018 DSH allotments,
the applicable historical percentage
change in the CPI–U for the previous FY
(FY 2017) was 2.1 percent; we note that
this is lower than the estimated 2.4
percentage change in the CPI–U for FY
2017 that was available and used in the
calculation of the preliminary FY 2018
DSH allotments which were published
in the July 6, 2018 Federal Register (83
FR 31536).
2. Final FY 2019 FS State DSH
Allotments
Addendum 2 to this notice provides
the States’ final FY 2019 DSH
allotments determined in accordance
with section 1923(f)(3) of the Act. As
described in the background section, in
general, the DSH allotment for a FY is
calculated by increasing the FY DSH
allotment for the preceding FY by the
CPI–U increase for the previous fiscal
year. For purposes of calculating the
States’ final FY 2019 DSH allotments,
the preceding final fiscal year DSH
allotments (for FY 2018) are being
published in this notice. For purposes of
calculating the States’ final FY 2019
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
DSH allotments we are using the actual
Medicaid expenditures for FY 2019.
Finally, for purposes of calculating the
States’ final FY 2019 DSH allotments,
the applicable historical percentage
change in the CPI–U for the previous FY
(FY 2018) was 2.4 percent; we note that
this is the same as the estimated 2.4
percentage change in the CPI–U for FY
2018 that was available and used in the
calculation of the preliminary FY 2019
DSH allotments which were published
in the February 11, 2019 Federal
Register (84 FR 3169).
3. Calculation of the Preliminary FY
2020 FS State DSH Allotments
Addendum 3 to this notice provides
the preliminary FY 2020 DSH
allotments determined in accordance
with section 1923(f)(3) of the Act. The
preliminary FY 2020 DSH allotments
contained in this notice were
determined based on the most recent
available estimates from States of their
FY 2020 total computable Medicaid
expenditures and by increasing the
preliminary FY 2019 DSH allotments.
The applicable historical percentage
change in the CPI–U for FY 2019 was
1.9 percent (we originally published the
preliminary FY 2019 DSH allotments in
the February 11, 2019 Federal Register
(84 FR 3169)). We then used each State’s
FS DSH allotment divided by its
respective regular FMAP rate in order to
determine the TC amount of DSH
payments each State would have
otherwise been able to make without
application of the FFCRA-increased
FMAP rate. We then multiplied each
State’s TC DSH payment amount by its
respective FFCRA-increased FMAP rate
in order to calculate the increased FY
2020 DSH allotment.
We will publish States’ final FY 2020
DSH allotments in a future notice based
on the States’ four quarterly Medicaid
expenditure reports (Form CMS–64) for
FY 2020 available following the end of
FY 2020 utilizing the actual change in
the CPI–U for FY 2019.
4. Calculation of the Preliminary FY
2021 FS State DSH Allotments
Addendum 4 to this notice provides
the preliminary FY 2021 DSH
allotments determined in accordance
with section 1923(f)(3) of the Act. The
preliminary FY 2021 DSH allotments
contained in this notice were
determined based on the most recent
available estimates from States of their
FY 2021 total computable Medicaid
expenditures and by increasing the
preliminary FY 2020 DSH allotments
calculated prior to the application of the
ARP adjustment. The applicable
historical percentage change in the CPI–
PO 00000
Frm 00041
Fmt 4703
Sfmt 4703
U for FY 2020 was 1.5 percent (we are
publishing the preliminary FY 2020
DSH allotments in this notice). We then
used each State’s FS DSH allotment
divided by its respective regular FMAP
rate in order to determine the TC
amount of DSH payments each State
would have otherwise been able to make
without application of the FFCRAincreased FMAP rate. We then
multiplied each State’s TC DSH
payment amount by its respective
FFCRA-increased FMAP rate in order to
calculate the ARP-adjusted FY 2021
DSH allotment.
We will publish States’ final FY 2021
DSH allotments in a future notice based
on the States’ four quarterly Medicaid
expenditure reports (Form CMS–64) for
FY 2021 available following the end of
FY 2021.
B. Calculation of the Final FY 2018 and
FY 2019 and Preliminary FY 2020 and
FY 2021 IMD DSH Limits
Section 1923(h) of the Act specifies
the methodology to be used to establish
the limits on the amount of DSH
payments that a State can make to IMDs
and other mental health facilities. FFP
is not available for DSH payments to
IMDs or other mental health facilities
that exceed the IMD DSH limits. In this
notice, we are publishing the final FY
2018 and FY 2019 and the preliminary
FY 2020 and FY 2021 IMD DSH limits
determined in accordance with the
provisions discussed above.
Addendums 5 through 8 to this notice
detail each State’s final FY 2018 and FY
2019 and preliminary FY 2020 and FY
2021 IMD DSH limits, respectively,
determined in accordance with section
1923(h) of the Act.
III. Collection of Information
Requirements
As it relates to the Paperwork
Reduction Act of 1995 (PRA; 44 U.S.C.
3501 et seq.), this notice does not
impose any new or revised ‘‘collection
of information’’ requirements or burden.
With respect to the PRA and this section
of the preamble, collection of
information is defined under 5 CFR
1320.3(c) of the PRA’s implementing
regulations. While discussed in sections
I.B., I.C., II.A.3., II.A.4., and in
Addendums 3 through 8 of this notice,
the requirements and burden associated
with form CMS–37 and form CMS–64
are unaffected by this notice. Both forms
are approved by the Office of
Management and Budget (OMB) under
control number 0938–1265, which
expires on April 30, 2024. Since this
notice will not impose any new or
revised collection of information
requirements/burden, we are not
E:\FR\FM\16MRN1.SGM
16MRN1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES1
making any changes under that control
number.
IV. Regulatory Impact Analysis
We have examined the impact of this
notice as required by Executive Order
12866 on Regulatory Planning and
Review (September 1993), the
Regulatory Flexibility Act (RFA)
(September 19, 1980, Pub. L. 96–354),
section 1102(b) of the Act, section 202
of the Unfunded Mandates Reform Act
of 1995 (Pub. L. 104–4; enacted on
March 22, 1995) (UMRA ‘95), Executive
Order 13132 on Federalism (August 4,
1999) and the Congressional Review Act
(5 U.S.C. 804(2)).
Executive Order 12866 directs
agencies to assess all costs and benefits
of available regulatory alternatives and,
if regulation is necessary, to select
regulatory approaches that maximize
net benefits (including potential
economic, environmental, public health
and safety effects, distributive impacts,
and equity). A regulatory impact
analysis (RIA) must be prepared for
major rules with economically
significant effects ($100 million or more
in any 1 year). This notice reaches the
$100 million economic threshold and
thus has been designated a major rule
under the Congressional Review Act by
the Office of Information and Regulatory
Affairs.
The final FY 2018 DSH allotments
being published in this notice are $36
million less than the preliminary FY
2018 DSH allotments published in the
July 6, 2018 Federal Register (83 FR
31536). This is due to the actual
percentage change in the CPI–U for FY
2017 used in the calculation of the final
FY 2018 allotments (2.1 percent) being
less than the estimated percentage
change in the CPI–U for FY 2017 used
in the calculation of the preliminary FY
2018 allotments (2.4 percent). The final
FY 2018 IMD DSH limits being
published in this notice are $2.4 million
less than the preliminary FY 2018 IMD
DSH limits published in the July 6, 2018
Federal Register (83 FR 31536). Since
the final FY 2018 DSH allotments were
less than the preliminary FY 2018 DSH
allotments, the associated FY 2018 IMD
DSH limits also decreased.
The final FY 2019 DSH allotments
being published in this notice are $36
million less than the preliminary FY
2019 DSH allotments published in the
February 11, 2019 Federal Register (84
FR 3169). The decrease in the final FY
2019 DSH allotments is a result of being
calculated by multiplying the actual
increase in the CPI–U for 2018 by the
final FY 2018 DSH allotments, while the
preliminary FY 2019 DSH allotments
were calculated by multiplying the
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
estimated CPI–U for 2018 by the
preliminary FY 2018 DSH allotments.
Although the estimated and actual
increase in the CPI–U remained the
same at 2.4 percent, the preliminary FY
2018 DSH allotments were higher than
the final FY 2018 DSH allotments and
therefore the final FY 2019 DSH
allotments are lower than the
preliminary FY 2019 DSH allotments.
The final FY 2019 IMD DSH limits being
published in this notice are
approximately $2 million lower than the
preliminary FY 2019 IMD DSH limits
published in the February 11, 2019
Federal Register (84 FR 3169). The
decreases in the IMD DSH limits are
because the DSH allotment for a FY is
a factor in the determination of the IMD
DSH limit for the FY. Since the final FY
2019 DSH allotments were decreased as
compared to the preliminary FY 2019
DSH allotments, the associated FY 2019
IMD DSH limits for some States were
also decreased. This is a result of
statutory provision, discussed above,
that the aggregate limit for DSH
payments to IMDs and other mental
health facilities is the lesser of a State’s
FY 1995 total computable IMD and
other mental health facility DSH
expenditures applicable to the State’s
FY 1995 DSH allotment or the amount
equal to the product of the State’s
current year total computable DSH
allotment and the applicable percentage
specified in section 1923(h) of the Act.
As a result of the final FY 2019 DSH
allotments decreasing from the
preliminary FY 2019 DSH allotments,
States that had applicable percentages of
their current year’s total computable
DSH allotments lower than FY 1995
total computable IMD and other mental
health facility DSH expenditures had
their IMD limits decreased as a result.
The preliminary FY 2020 DSH
allotments being published in this
notice have been increased by
approximately $1.6 billion more than
the preliminary FY 2019 DSH
allotments published in the February
11, 2019 Federal Register (84 FR 3169).
The increase in the DSH allotments is
due to the application of the statutory
formula for calculating DSH allotments
under which the prior fiscal year
allotments are increased by the
percentage increase in the CPI–U for the
prior fiscal year, and to the ARP
adjustment, as discussed in more detail
in the next paragraph. The preliminary
FY 2020 IMD DSH limits being
published in this notice are
approximately $246 million more than
the preliminary FY 2019 IMD DSH
limits published in the February 11,
2019 Federal Register (84 FR 3169). The
PO 00000
Frm 00042
Fmt 4703
Sfmt 4703
14861
increases in the IMD DSH limits are
because the DSH allotment for a FY is
a factor in the determination of the IMD
DSH limit for the FY. Since the
preliminary FY 2020 DSH allotments
are greater than the preliminary FY 2019
DSH allotments, the associated
preliminary FY 2020 IMD DSH limits
for some States also increased.
The preliminary FY 2020 DSH
allotments (before application of the
ARP adjustment) being published in this
in this notice are approximately $238
million more than the final FY 2019
DSH allotments being published in this
notice. This increase is attributable to
the application of the statutory formula
for calculating DSH allotments under
which the prior fiscal year allotments
are increased by the percentage increase
in the CPI–U for the prior fiscal year.
The applicable historical percentage
change in the CPI–U for FY 2019 was
1.9 percent. The preliminary FY 2020
DSH allotments were further increased
by approximately $1.4 billion in order
to comply with the statutory provisions
of the ARP requiring us to recalculate
FS DSH allotments to an amount that
will allow States to make the same
amount of TC DSH payments as they
would have been otherwise able to make
in the absence of the FFCRA FMAP
increase.
The preliminary FY 2021 DSH
allotments (before application of the
ARP adjustment) being published in this
notice are approximately $192 million
more than the preliminary FY 2020 DSH
allotments published in this notice. The
increase in the DSH allotments is due to
the application of the statutory formula
for calculating DSH allotments under
which the prior fiscal year allotments
are increased by the percentage increase
in the CPI–U for the prior fiscal year.
The applicable historical percentage
change in the CPI–U for FY 2020 was
1.5 percent. The preliminary FY 2020
DSH allotments were increased by
approximately $1.4 billion in order to
comply with the statutory provisions of
the ARP requiring us to recalculate FS
DSH allotments to an amount that will
allow States to make the same amount
of TC DSH payments as they would
have been otherwise able to make in the
absence of the FFCRA FMAP increase.
The preliminary FY 2021 DSH
allotments were further increased by
approximately $1.4 billion in order to
comply with the statutory provisions of
the ARP requiring us to recalculate FS
DSH allotments to an amount that will
allow States to make the same amount
of TC DSH payments as they would
have been otherwise able to make in the
absence of the FFCRA FMAP increase.
E:\FR\FM\16MRN1.SGM
16MRN1
jspears on DSK121TN23PROD with NOTICES1
14862
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
The preliminary FY 2021 IMD DSH
limits being published in this notice are
approximately $16 million more than
the preliminary FY 2020 IMD DSH
limits published in this notice. The
increases in the IMD DSH limits are
because the DSH allotment for a FY is
a factor in the determination of the IMD
DSH limit for the FY. Since the
preliminary FY 2021 DSH allotments
are greater than the preliminary FY 2020
DSH allotments, the associated
preliminary FY 2021 IMD DSH limits
for some States also increased.
The RFA requires agencies to analyze
options for regulatory relief of small
businesses, if a rule has a significant
impact on a substantial number of small
entities. For purposes of the RFA, small
entities include small businesses,
nonprofit organizations, and small
governmental jurisdictions. Most
hospitals and most other providers and
suppliers are small entities, either by
nonprofit status or by having revenues
of less than $8.0 million to $41.5
million in any one year. Individuals and
States are not included in the definition
of a small entity. We are not preparing
an analysis for the RFA because the
Secretary has determined that this
notice will not have significant
economic impact on a substantial
number of small entities. Specifically,
any impact on providers is due to the
effect of the various controlling statutes;
providers are not impacted as a result of
the independent regulatory action in
publishing this notice. The purpose of
the notice is to announce the latest DSH
allotments and IMD DSH limits, as
required by the statute.
In addition, section 1102(b) of the Act
requires us to prepare a regulatory
impact analysis if a rule may have a
significant impact on the operations of
a substantial number of small rural
hospitals. This analysis must conform to
the provisions of section 604 of the
RFA. For purposes of section 1102(b) of
the Act, we define a small rural hospital
as a hospital that is located outside of
a Core-Based Statistical Area for
Medicaid payment regulations and has
fewer than 100 beds. We are not
preparing analysis for section 1102(b) of
the Act because the Secretary has
determined that this notice will not
have a significant impact on the
operations of a substantial number of
small rural hospitals.
The Medicaid statute specifies the
methodology for determining the
amounts of States’ DSH allotments and
IMD DSH limits; and as described
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
previously, the application of the
methodology specified in statute results
in the decreases or increases in States’
DSH allotments and IMD DSH limits for
the applicable FYs. The statute
applicable to these allotments and limits
does not apply to the determination of
the amounts of DSH payments made to
specific DSH hospitals; rather, these
allotments and limits represent an
overall limit on the total of such DSH
payments. For this reason, we do not
believe that this notice will have a
significant economic impact on a
substantial number of small entities.
Section 202 of the Unfunded
Mandates Reform Act of 1995 also
requires that agencies assess anticipated
costs and benefits before issuing any
rule whose mandates require spending
in any 1 year of $100 million in 1995
dollars, updated annually for inflation.
In 2021, that threshold is approximately
$158 million. This notice will have no
consequential effect on spending by
State, local, or tribal governments, in the
aggregate, or on the private sector.
Executive Order 13132 establishes
certain requirements that an agency
must meet when it issues a proposed
rule (and subsequent final rule) that
imposes substantial direct requirement
costs on State and local governments,
preempts State law, or otherwise has
Federalism implications. Since this
notice does not impose any costs on
State or local governments or otherwise
have Federalism implications, the
requirements of E.O. 13132 are not
applicable.
A. Alternatives Considered
Because the FFCRA temporary FMAP
increase of 6.2 percentage points was
not applicable to the 1st quarter of FY
2020, we considered utilizing prorated
FMAP rates in the calculation of the
ARP-adjusted FY 2020 DSH allotments.
However, this could have been contrary
to the statutory language at section
1923(f)(3)(F) of the Act requiring us to
recalculate FS DSH allotments to an
amount to allow for States to make the
same amount of TC DSH payments as
they would have been otherwise able to
make in the absence of the FFCRA
FMAP increase, depending on States’
timing of their DSH payments to eligible
providers. The methodologies for
determining the States’ fiscal year DSH
allotments and IMD DSH limits, as
reflected in this notice, were established
in accordance with the methodologies
and formula for determining States’
allotments and limits as specified in
statute. This notice does not put forward
PO 00000
Frm 00043
Fmt 4703
Sfmt 4703
any further discretionary administrative
policies for determining such allotments
and limits, or otherwise.
B. Accounting Statement
As required by OMB Circular A–4
(available at https://obamawhitehouse.
archives.gov/omb/circulars_a004_a-4/),
in Tables 1 and 2, we have prepared an
accounting statement showing the
classification of the estimated
expenditures associated with the
provisions of this notice. Table 1
provides our best estimate of the change
(decrease) in the FS of States’ Medicaid
DSH payments resulting from the
application of the provisions of the
Medicaid statute relating to the
calculation of States’ FY DSH allotments
and the increase in the FY DSH
allotments from FY 2019 to FY 2020.
Table 2 provides our best estimate of the
change (decrease) in the FS of States’
Medicaid DSH payments resulting from
the application of the provisions of the
Medicaid statute relating to the
calculation of States’ FY DSH allotments
and the increase in the FY DSH
allotments from FY 2020 to FY 2021.
TABLE 1—ACCOUNTING STATEMENT:
CLASSIFICATION OF ESTIMATED EXPENDITURES, FROM THE FY 2019 TO
FY 2020
[In millions]
Category
Transfers
Annualized Monetized
Transfers.
From Whom To
Whom?
$238.
Federal Government
to States.
TABLE 2—ACCOUNTING STATEMENT:
CLASSIFICATION OF ESTIMATED EXPENDITURES, FROM THE FY 2020 TO
FY 2021
[In millions]
Category
Annualized Monetized
Transfers.
From Whom To
Whom?
Transfers
$192.
Federal Government
to States.
C. Congressional Review Act
This document is subject to the
Congressional Review Act provisions of
the Small Business Regulatory
Enforcement Fairness Act of 1996 (5
U.S.C. 801 et seq.) and has been
transmitted to the Congress and the
Comptroller General for review.
E:\FR\FM\16MRN1.SGM
16MRN1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
jspears on DSK121TN23PROD with NOTICES1
In accordance with the provisions of
Executive Order 12866, this notice was
reviewed by the Office of Management
and Budget.
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
Chiquita Brooks-LaSure,
Administrator of the Centers for
Medicare & Medicaid Services,
approved this document on February 1,
2022.
PO 00000
Frm 00044
Fmt 4703
Sfmt 4703
14863
Dated: March 9, 2022.
Xavier Becerra,
Secretary, Department of Health and Human
Services.
BILLING CODE 4120–01–P
E:\FR\FM\16MRN1.SGM
16MRN1
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00045
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.006
jspears on DSK121TN23PROD with NOTICES1
14864
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00046
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14865
EN16MR22.007
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00047
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.008
jspears on DSK121TN23PROD with NOTICES1
14866
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00048
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14867
EN16MR22.009
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00049
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.010
jspears on DSK121TN23PROD with NOTICES1
14868
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00050
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14869
EN16MR22.011
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00051
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.012
jspears on DSK121TN23PROD with NOTICES1
14870
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00052
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14871
EN16MR22.013
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00053
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.014
jspears on DSK121TN23PROD with NOTICES1
14872
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00054
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14873
EN16MR22.016
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00055
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.017
jspears on DSK121TN23PROD with NOTICES1
14874
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00056
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14875
EN16MR22.018
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00057
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.020
jspears on DSK121TN23PROD with NOTICES1
14876
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00058
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14877
EN16MR22.021
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00059
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.022
jspears on DSK121TN23PROD with NOTICES1
14878
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00060
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14879
EN16MR22.023
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00061
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.024
jspears on DSK121TN23PROD with NOTICES1
14880
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00062
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14881
EN16MR22.025
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00063
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.026
jspears on DSK121TN23PROD with NOTICES1
14882
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00064
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14883
EN16MR22.027
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00065
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.028
jspears on DSK121TN23PROD with NOTICES1
14884
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00066
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
14885
EN16MR22.029
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
VerDate Sep<11>2014
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00067
Fmt 4703
Sfmt 4725
E:\FR\FM\16MRN1.SGM
16MRN1
EN16MR22.030
jspears on DSK121TN23PROD with NOTICES1
14886
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
PO 00000
Frm 00068
Fmt 4703
Sfmt 9990
E:\FR\FM\16MRN1.SGM
16MRN1
14887
EN16MR22.031
jspears on DSK121TN23PROD with NOTICES1
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
14888
Federal Register / Vol. 87, No. 51 / Wednesday, March 16, 2022 / Notices
[FR Doc. 2022–05459 Filed 3–14–22; 4:15 pm]
BILLING CODE 4120–01–C
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2022–N–0284]
Over-the-Counter Monograph Drug
User Fee Rates for Fiscal Year 2022
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA or the Agency) is
announcing the fee rates under the overthe-counter (OTC) monograph drug user
fee program (OMUFA) for fiscal year
(FY) 2022. The Federal Food, Drug, and
Cosmetic Act (FD&C Act) authorizes
FDA to assess and collect user fees from
qualifying manufacturers of OTC
monograph drugs and submitters of
OTC monograph order requests. This
notice publishes the OMUFA fee rates
for FY 2022.
FOR FURTHER INFORMATION CONTACT:
David Haas, Office of Financial
Management, Food and Drug
Administration, 4041 Powder Mill Rd.,
Rm. 61075, Beltsville, MD 20705–4304,
240–402–9845.
SUPPLEMENTARY INFORMATION:
SUMMARY:
jspears on DSK121TN23PROD with NOTICES1
I. Background
Section 744M of the FD&C Act (21
U.S.C. 379j–72), as added by the
Coronavirus Aid, Relief, and Economic
Security Act (CARES Act), authorizes
FDA to assess and collect: (1) Facility
fees from qualifying owners of OTC
monograph drug facilities and (2) fees
from submitters of qualifying OTC
monograph order requests. These fees
are to support FDA’s OTC monograph
drug activities, which are detailed in
section 744L(6) of the FD&C Act (21
U.S.C. 379j–71(6)) and include various
FDA activities associated with OTC
monograph drugs and inspection of
facilities associated with such products.
For OMUFA purposes:
• An OTC monograph drug is a
nonprescription drug without an
approved new drug application that is
governed by the provisions of section
505G of the FD&C Act (21 U.S.C. 355h)
(see section 744L(5) of the FD&C Act);
• An OTC monograph drug facility
(MDF) is a foreign or domestic business
or other entity that, in addition to
meeting other criteria, is engaged in
manufacturing or processing the
finished dosage form of an OTC
VerDate Sep<11>2014
17:16 Mar 15, 2022
Jkt 256001
monograph drug (see section 744L(10)
of the FD&C Act);
• A contract manufacturing
organization (CMO) facility is an OTC
monograph drug facility where neither
the owner nor any affiliate of the owner
or facility sells the OTC monograph
drug produced at such facility directly
to wholesalers, retailers, or consumers
in the United States (see section 744L(2)
of the FD&C Act); and
• An OTC monograph order request
(OMOR) is a request for an
administrative order, with respect to an
OTC monograph drug, which is
submitted under section 505G(b)(5) of
the FD&C Act (see section 744L(7) of the
FD&C Act).
Under section 744M(a)(1)(A) of the
FD&C Act, a facility fee for FY 2022
shall be assessed with respect to each
facility that is identified as an OTC
monograph drug facility during the feeliable period from January 1, 2021,
through December 31, 2021.1 Consistent
with the statute, FDA will assess and
collect facility fees with respect to the
two types of OTC monograph drug
facilities—MDF and CMO facilities. A
full facility fee will be assessed to each
qualifying person that owns a facility
identified as an MDF (see section
744M(a)(1)(A) of the FD&C Act), and a
reduced facility fee of two-thirds will be
assessed to each qualifying person that
owns a facility identified as a CMO
facility (see section 744M(a)(1)(B)(ii) of
the FD&C Act). The facility fees for FY
2022 are due on June 1, 2022 (see
section 744M(a)(1)(D)(ii) of the FD&C
Act).2
As discussed in greater detail below:
• OTC monograph drug facilities are
exempt from FY 2022 facility fees if
they had ceased OTC monograph drug
activities, and updated their registration
with FDA to that effect, prior to
December 31, 2020 (see section
744M(a)(1)(B)(i) of the FD&C Act).
• Entities that registered with FDA
during the Coronavirus Disease 2019
(COVID–19) pandemic whose sole
activity with respect to OTC monograph
drugs during the pandemic consists (or
had consisted) of manufacturing OTC
1 Under section 744M(a)(1) of the FD&C Act,
‘‘Each person that owns a facility identified as an
OTC monograph drug facility on December 31 of
the fiscal year or at any time during the preceding
12-month period shall be assessed an annual fee for
each such facility’’. For purposes of FY 2022 facility
fees, that time period is January 1, 2021, through
December 31, 2021.
2 Assuming that, as we anticipate, the FY 2022 fee
appropriation will occur prior to June 1, 2022.
Under section 744M(a)(1)(D)(ii), the FY 2022
facility fees are due on the later of (1) the first
business day of June 2022 (i.e., June 1, 2022) or (2)
the first business day after the enactment of an
appropriations Act providing for the collection and
obligation of FY 2022 OMUFA fees.
PO 00000
Frm 00069
Fmt 4703
Sfmt 4703
hand sanitizer products 3 are not
identified as OTC monograph drug
facilities subject to OMUFA facility
fees.4
In addition to facility fees, the Agency
is authorized to assess and collect fees
from submitters of OMORs, except for
OMORs that request certain safetyrelated changes (as discussed below).
There are two levels of OMOR fees,
based on whether the OMOR at issue is
a Tier 1 or Tier 2 OMOR.5
For FY 2022, the OMUFA fee rates
are: Tier 1 OMOR fees ($507,021), Tier
2 OMOR fees ($101,404), MDF facility
fees ($24,178), and CMO facility fees
($16,119). These fees are effective for
the period from October 1, 2021,
through September 30, 2022.6 This
document is issued pursuant to sections
744M(a)(4) and 744M(c)(4)(B) of the
FD&C Act and describes the calculations
used to set the OMUFA facility fees and
OMOR fees for FY 2022 in accordance
with the directives in the statute.
II. Facility Fee Revenue Amount for FY
2022
A. Base Fee Revenue Amount
Under OMUFA, FDA sets annual
facility fees to generate the total facility
fee revenues for each fiscal year
established by section 744M(b) of the
FD&C Act. The yearly base revenue
amount is the starting point for setting
annual facility fee rates. The base
revenue for FY 2022 is the dollar
amount of the total revenue amount for
the previous fiscal year, without certain
adjustments made for that previous
year, and is $8,000,000 (see section
744M(b)(3)(B) of the FD&C Act).
B. Fee Revenue Adjustment for Inflation
Under OMUFA, the annual base
revenue amount for facility fees is
3 The term ‘‘hand sanitizer’’ commonly refers to
consumer antiseptic rubs. However, because the
Health and Human Services (HHS) notice published
January 12, 2021, referred to ‘‘persons that entered
the over-the-counter drug market to supply hand
sanitizer products in response to the COVID–19
Public Health Emergency’’ (86 FR 2420,https://
www.federalregister.gov/documents/2021/01/12/
2021–00237/notice-that-persons-that-entered-theover-the-counter-drug-market-to-supply-handsanitizer-during), we are using the same
terminology—‘‘hand sanitizer products’’—to refer to
OTC monograph drug products intended for use
(without water) as antiseptic hand rubs or antiseptic
hand wipes by consumers or healthcare personnel.
4 See HHS Federal Register notice of January 12,
2021, 86 FR 2420, https://www.federalregister.gov/
documents/2021/01/12/2021-00237/notice-thatpersons-that-entered-the-over-the-counter-drugmarket-to-supply-hand-sanitizer-during.
5 Under OMUFA, a Tier 1 OMOR is defined as
any OMOR that is not a Tier 2 OMOR (see section
744L(8) of the FD&C Act). Tier 2 OMORs are
detailed in section 744L(9) of the FD&C Act.
6 These OMUFA fees are for FY 2022, per section
744M(a) of the FD&C Act.
E:\FR\FM\16MRN1.SGM
16MRN1
Agencies
[Federal Register Volume 87, Number 51 (Wednesday, March 16, 2022)]
[Notices]
[Pages 14858-14888]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05459]
=======================================================================
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-2436-N]
RIN 0938-ZB62
Medicaid Program; Final FY 2018, Final FY 2019, Preliminary FY
2020, and Preliminary FY 2021 Disproportionate Share Hospital
Allotments, and Final FY 2018, Final FY 2019, Preliminary FY 2020, and
Preliminary FY 2021 Institutions for Mental Diseases Disproportionate
Share Hospital Limits
AGENCY: Centers for Medicare & Medicaid Services (CMS), Department of
Health and Human Services (HHS).
ACTION: Notice.
-----------------------------------------------------------------------
SUMMARY: This notice announces the final Federal share (FS)
disproportionate share hospital (DSH) allotments for Federal fiscal
year (FY) 2018 and FY 2019, and the preliminary FS DSH allotments for
FY 2020 and FY 2021. This notice also announces the final FY 2018 and
FY 2019 and the preliminary FY 2020 and FY 2021 limitations on
aggregate DSH payments that States may make to institutions for mental
disease and other mental health facilities. In addition, this notice
includes background information describing the methodology for
determining the amounts of States' FY DSH allotments.
DATES: The allotments announced in this notice are effective April 15,
2022. The final allotments and limitations set forth in this notice are
applicable for the fiscal years specified.
FOR FURTHER INFORMATION CONTACT: Stuart Goldstein, (410) 786-0694 and
Richard Cuno, (410) 786-1111.
SUPPLEMENTARY INFORMATION:
I. Background
A. Fiscal Year DSH Allotments
A State's Federal fiscal year (FY) disproportionate share hospital
(DSH) allotment represents the aggregate limit on the Federal share
(FS) amount of the State's DSH payments to DSH hospitals in the State
for the FY. The amount of such allotment is determined in accordance
with the provisions of section 1923(f) of the Social Security Act (the
Act), with some State-specific exceptions as specified in section
1923(f) of the Act. Under such provisions, in general, a State's FY DSH
allotment is calculated by increasing the amount of its DSH allotment
for the preceding FY by the percentage change in the Consumer Price
Index for all Urban Consumers (CPI-U) for the previous FY.
The Patient Protection and Affordable Care Act of 2010 (Pub. L.
111-148), as amended by the Health Care and Education Reconciliation
Act of 2010 (Pub. L. 111-152) (collectively, the Affordable Care Act),
amended Medicaid DSH provisions, adding section 1923(f)(7) of the Act.
Section 1923(f)(7) of the Act would have required reductions to States'
FY DSH allotments from FY 2014 through FY 2020, the calculation of
which was described in the Disproportionate Share Hospital Payment
Reduction final rule published in the September 18, 2013 Federal
Register (78 FR 57293). Subsequent legislation, most recently the
Consolidated Appropriations Act, 2021 (Pub. L. 116-260, enacted
December 27, 2020), delayed the start of these reductions until FY
2024. The final rule delineating a revised methodology for the
calculation of DSH allotment reductions beginning in 2020 (subsequently
delayed by further statutory enactment) was published in the September
25, 2019 Federal Register (84 FR 50308).
Because there are no reductions to DSH allotments for FY 2018
through FY 2023 under section 1923(f)(7) of the Act, as amended, this
notice contains only the State-specific final FY 2018 and FY 2019 DSH
allotments and preliminary FY 2020 and FY 2021 DSH allotments, as
calculated under the statute without application of the reductions that
would have been imposed beginning as early as FY 2014 under prior
versions of section 1923(f)(7) of the Act. This notice also provides
information on the calculation of the FY DSH allotments, the
calculation of the States' institution for mental diseases (IMD) DSH
limits, and the amounts of States' final FY 2018 and FY 2019 IMD DSH
limits and preliminary FY 2020 and FY 2021 IMD DSH limits.
B. Determination of Fiscal Year DSH Allotments
Generally, in accordance with the methodology specified under
section 1923(f)(3) of the Act, a State's FY DSH allotment is calculated
by increasing the amount of its DSH allotment for the preceding FY by
the percentage change in the CPI-U for the previous FY. Also, in
accordance with section 1923(f)(3) of
[[Page 14859]]
the Act, a State's DSH allotment for a FY is subject to the limitation
that an increase to a State's DSH allotment for a FY cannot result in
the DSH allotment exceeding the greater of the State's DSH allotment
for the previous FY or 12 percent of the State's total medical
assistance expenditures for the allotment year (this is referred to as
the 12 percent limit).
Furthermore, under section 1923(h) of the Act, Federal financial
participation (FFP) for DSH payments to IMDs and other mental health
facilities is limited to State-specific aggregate amounts. Under this
provision, the aggregate limit for DSH payments to IMDs and other
mental health facilities is the lesser of a State's FY 1995 total
computable (State and FS) IMD and other mental health facility DSH
expenditures applicable to the State's FY 1995 DSH allotment (as
reported on the Form CMS-64 as of January 1, 1997), or the amount equal
to the product of the State's current year total computable DSH
allotment and the applicable percentage specified in section 1923(h) of
the Act.
C. Determination of Fiscal Year DSH Allotments for FY 2020 and FY 2021
The Families First Coronavirus Response Act's (FFCRA) (Pub. L. 116-
127, enacted March 18, 2020) temporary Federal medical assistance
percentage (FMAP) increase of 6.2 percentage points went into effect on
January 1, 2020 for eligible States, as provided in section 6008 of the
FFCRA. As relevant to this notice, this FMAP increase applies to
eligible Medicaid expenditures including DSH payments for FY 2020 (with
the exception of the 1st quarter, from October 1, 2019 through December
31, 2019), and FY 2021, and all States currently are receiving the
temporary FFCRA FMAP increase. For States that exhaust their entire DSH
allotment, the FFCRA FMAP increase would effectively reduce the amount
of total computable (TC) DSH payments that such States could pay to
qualifying providers.
To avoid this reduction in TC DSH allotments, section 9819 of the
American Rescue Plan Act of 2021 (ARP) (Pub. L. 117-2, enacted March
11, 2021) added section 1923(f)(3)(F) of the Act, adjusting FS DSH
allotments during periods when and for States where the temporary 6.2
percentage point FMAP increase under section 6008 of the FFCRA is in
effect. As directed by the ARP, we are required to recalculate FS DSH
allotments to an amount that will allow States to make the same amount
of TC DSH payments as they would have been otherwise able to make in
the absence of the FFCRA FMAP increase.
In accordance with section 1923(f)(3)(B) of the Act, a State's DSH
allotment for a FY is subject to the limitation that an increase to a
State's DSH allotment for a FY cannot result in the DSH allotment
exceeding the greater of the State's DSH allotment for the previous FY
or 12 percent of the State's total medical assistance expenditures for
the allotment year. Because States incur medical assistance
expenditures throughout the fiscal year, the calculations for the 12
percent limit under section 1923(f)(3)(B)(ii) of the Act were performed
using a prorated FMAP for FY 2020. To arrive at the stated limits, we
prorated each State's FY 2020 FMAP rate because the temporary 6.2
percentage point FMAP increase under section 6008 of the FFCRA does not
apply to the 1st quarter of FY 2020. For the calculation of the 12
percent limit for FY 2021, we used the FFCRA FMAP rate (that is, the
otherwise applicable FMAP rate plus the temporary 6.2 percentage point
FFCRA FMAP increase), because the FFCRA FMAP rate applies to the entire
FY for qualifying States, and medical assistance expenditures are made
throughout the year.
Section 1923(f)(3)(F)(i) of the Act requires us to recalculate the
annual DSH allotment, including the DSH allotment specified under
paragraph (6)(A)(vi), to ensure that the total DSH payments (including
both Federal and State shares) that a State may make related to a
fiscal year is equal to the total DSH payments that the State could
have made for such fiscal year without such FMAP increase. To meet the
statutory requirement to enable States to make the same amount of TC
DSH payments as if the FFCRA FMAP increase were not in effect, we have
used the full (non-prorated) FFCRA-increased FMAP rate in the
calculation of the increased FY 2020 and FY 2021 FS DSH allotments. We
used the full FFCRA-increased FMAP rate rather than a prorated FMAP
rate for the FY 2020 calculation, despite it not being applicable to
the 1st quarter of FY 2020, to ensure this provision applies to all
States consistent with the statutory requirement, including a State
that made all DSH payments for FY 2020 in quarters other than the first
fiscal quarter of that fiscal year.
While States have distinct payment methodologies that specify when
DSH payments are made to providers, States may not claim TC DSH
payments in excess of the amount they would have otherwise been able to
claim without the application of the temporary 6.2 percentage point
FFCRA FMAP rate increase. This is regardless of whether a portion of
unspent FS DSH allotment as adjusted to account for section
1923(f)(3)(F) of the Act, as added by section 9819 of the ARP, remains.
For example, if the State made all DSH payments for FY 2020 during the
first quarter of that FY, then no increase to the State's DSH allotment
is available for that year, since the temporary 6.2 percentage point
FMAP increase under section 6008 of the FFCRA was not available for
that quarter and section 1923(f)(3)(F) therefore has no effect. We will
monitor both the FS and TC DSH allotments to ensure that States do not
exceed statutory authority to claim DSH payments. Consistent with
previous guidance by CMS during the public health emergency, States
should follow existing Federal requirements regarding the applicability
of a particular match rate available for a given quarter, including
reporting prior period adjustments.
For calculation of the FY 2020 and FY 2021 IMD limits determined
under section 1923(h) of the Act, we used the ARP-adjusted DSH
allotments and the associated non-prorated FFCRA-increased FMAP rates
for FY 2020 and FY 2021, to reflect the maximum DSH allotment amount
and IMD limit that might be available to a State, for FY 2020,
depending on the State's timing of DSH payments.
In general, we determine States' DSH allotments for a FY and the
IMD DSH limits for the same FY using the most recent available
estimates of or actual medical assistance expenditures, including DSH
expenditures and the most recent available CPI-U data for the FY in
accordance with the methodology prescribed in the statute. The
indicated estimated or actual expenditures are obtained from States for
each relevant FY from the most recent available quarterly Medicaid
budget reports (Form CMS-37) or quarterly Medicaid expenditure reports
(Form CMS-64), respectively, submitted by the States. For example, as
part of the initial determination of a State's FY DSH allotment
(referred to as the preliminary DSH allotments) that is determined
before the beginning of the FY for which the DSH allotments and IMD DSH
limits are being determined, we use estimated expenditures for the FY
obtained from the August submission of the CMS-37 submitted by States
prior to the beginning of the FY; such estimated expenditures are
subject to update and revision during the FY before actual expenditure
data become available. We also use the most recent available estimated
CPI-U percentage change that
[[Page 14860]]
is available before the beginning of the FY for determining the States'
preliminary FY DSH allotments; such estimated CPI-U percentage change
is subject to update and revision during the FY before the actual CPI-U
percentage change becomes available. In determining the final DSH
allotments and IMD DSH limits for a FY we use the actual expenditures
for the FY and actual CPI-U percentage change for the previous FY.
II. Provisions of the Notice
A. Calculation of the Final FY 2018 and FY 2019 FS State DSH Allotments
and the Preliminary FY 2020 and FY 2021 FS State DSH Allotments
1. Final FY 2018 FS State DSH Allotments
Addendum 1 to this notice provides the States' final FY 2018 DSH
allotments determined in accordance with section 1923(f)(3) of the Act.
As described in the background section, in general, the DSH allotment
for a FY is calculated by increasing the FY DSH allotment for the
preceding FY by the CPI-U increase for the previous fiscal year. For
purposes of calculating the States' final FY 2018 DSH allotments, the
preceding final fiscal year DSH allotments (for FY 2017) were published
in the February 11, 2019 Federal Register (84 FR 3169). For purposes of
calculating the States' final FY 2018 DSH allotments we are using the
actual Medicaid expenditures for FY 2018. Finally, for purposes of
calculating the States' final FY 2018 DSH allotments, the applicable
historical percentage change in the CPI-U for the previous FY (FY 2017)
was 2.1 percent; we note that this is lower than the estimated 2.4
percentage change in the CPI-U for FY 2017 that was available and used
in the calculation of the preliminary FY 2018 DSH allotments which were
published in the July 6, 2018 Federal Register (83 FR 31536).
2. Final FY 2019 FS State DSH Allotments
Addendum 2 to this notice provides the States' final FY 2019 DSH
allotments determined in accordance with section 1923(f)(3) of the Act.
As described in the background section, in general, the DSH allotment
for a FY is calculated by increasing the FY DSH allotment for the
preceding FY by the CPI-U increase for the previous fiscal year. For
purposes of calculating the States' final FY 2019 DSH allotments, the
preceding final fiscal year DSH allotments (for FY 2018) are being
published in this notice. For purposes of calculating the States' final
FY 2019 DSH allotments we are using the actual Medicaid expenditures
for FY 2019. Finally, for purposes of calculating the States' final FY
2019 DSH allotments, the applicable historical percentage change in the
CPI-U for the previous FY (FY 2018) was 2.4 percent; we note that this
is the same as the estimated 2.4 percentage change in the CPI-U for FY
2018 that was available and used in the calculation of the preliminary
FY 2019 DSH allotments which were published in the February 11, 2019
Federal Register (84 FR 3169).
3. Calculation of the Preliminary FY 2020 FS State DSH Allotments
Addendum 3 to this notice provides the preliminary FY 2020 DSH
allotments determined in accordance with section 1923(f)(3) of the Act.
The preliminary FY 2020 DSH allotments contained in this notice were
determined based on the most recent available estimates from States of
their FY 2020 total computable Medicaid expenditures and by increasing
the preliminary FY 2019 DSH allotments. The applicable historical
percentage change in the CPI-U for FY 2019 was 1.9 percent (we
originally published the preliminary FY 2019 DSH allotments in the
February 11, 2019 Federal Register (84 FR 3169)). We then used each
State's FS DSH allotment divided by its respective regular FMAP rate in
order to determine the TC amount of DSH payments each State would have
otherwise been able to make without application of the FFCRA-increased
FMAP rate. We then multiplied each State's TC DSH payment amount by its
respective FFCRA-increased FMAP rate in order to calculate the
increased FY 2020 DSH allotment.
We will publish States' final FY 2020 DSH allotments in a future
notice based on the States' four quarterly Medicaid expenditure reports
(Form CMS-64) for FY 2020 available following the end of FY 2020
utilizing the actual change in the CPI-U for FY 2019.
4. Calculation of the Preliminary FY 2021 FS State DSH Allotments
Addendum 4 to this notice provides the preliminary FY 2021 DSH
allotments determined in accordance with section 1923(f)(3) of the Act.
The preliminary FY 2021 DSH allotments contained in this notice were
determined based on the most recent available estimates from States of
their FY 2021 total computable Medicaid expenditures and by increasing
the preliminary FY 2020 DSH allotments calculated prior to the
application of the ARP adjustment. The applicable historical percentage
change in the CPI-U for FY 2020 was 1.5 percent (we are publishing the
preliminary FY 2020 DSH allotments in this notice). We then used each
State's FS DSH allotment divided by its respective regular FMAP rate in
order to determine the TC amount of DSH payments each State would have
otherwise been able to make without application of the FFCRA-increased
FMAP rate. We then multiplied each State's TC DSH payment amount by its
respective FFCRA-increased FMAP rate in order to calculate the ARP-
adjusted FY 2021 DSH allotment.
We will publish States' final FY 2021 DSH allotments in a future
notice based on the States' four quarterly Medicaid expenditure reports
(Form CMS-64) for FY 2021 available following the end of FY 2021.
B. Calculation of the Final FY 2018 and FY 2019 and Preliminary FY 2020
and FY 2021 IMD DSH Limits
Section 1923(h) of the Act specifies the methodology to be used to
establish the limits on the amount of DSH payments that a State can
make to IMDs and other mental health facilities. FFP is not available
for DSH payments to IMDs or other mental health facilities that exceed
the IMD DSH limits. In this notice, we are publishing the final FY 2018
and FY 2019 and the preliminary FY 2020 and FY 2021 IMD DSH limits
determined in accordance with the provisions discussed above.
Addendums 5 through 8 to this notice detail each State's final FY
2018 and FY 2019 and preliminary FY 2020 and FY 2021 IMD DSH limits,
respectively, determined in accordance with section 1923(h) of the Act.
III. Collection of Information Requirements
As it relates to the Paperwork Reduction Act of 1995 (PRA; 44
U.S.C. 3501 et seq.), this notice does not impose any new or revised
``collection of information'' requirements or burden. With respect to
the PRA and this section of the preamble, collection of information is
defined under 5 CFR 1320.3(c) of the PRA's implementing regulations.
While discussed in sections I.B., I.C., II.A.3., II.A.4., and in
Addendums 3 through 8 of this notice, the requirements and burden
associated with form CMS-37 and form CMS-64 are unaffected by this
notice. Both forms are approved by the Office of Management and Budget
(OMB) under control number 0938-1265, which expires on April 30, 2024.
Since this notice will not impose any new or revised collection of
information requirements/burden, we are not
[[Page 14861]]
making any changes under that control number.
IV. Regulatory Impact Analysis
We have examined the impact of this notice as required by Executive
Order 12866 on Regulatory Planning and Review (September 1993), the
Regulatory Flexibility Act (RFA) (September 19, 1980, Pub. L. 96-354),
section 1102(b) of the Act, section 202 of the Unfunded Mandates Reform
Act of 1995 (Pub. L. 104-4; enacted on March 22, 1995) (UMRA `95),
Executive Order 13132 on Federalism (August 4, 1999) and the
Congressional Review Act (5 U.S.C. 804(2)).
Executive Order 12866 directs agencies to assess all costs and
benefits of available regulatory alternatives and, if regulation is
necessary, to select regulatory approaches that maximize net benefits
(including potential economic, environmental, public health and safety
effects, distributive impacts, and equity). A regulatory impact
analysis (RIA) must be prepared for major rules with economically
significant effects ($100 million or more in any 1 year). This notice
reaches the $100 million economic threshold and thus has been
designated a major rule under the Congressional Review Act by the
Office of Information and Regulatory Affairs.
The final FY 2018 DSH allotments being published in this notice are
$36 million less than the preliminary FY 2018 DSH allotments published
in the July 6, 2018 Federal Register (83 FR 31536). This is due to the
actual percentage change in the CPI-U for FY 2017 used in the
calculation of the final FY 2018 allotments (2.1 percent) being less
than the estimated percentage change in the CPI-U for FY 2017 used in
the calculation of the preliminary FY 2018 allotments (2.4 percent).
The final FY 2018 IMD DSH limits being published in this notice are
$2.4 million less than the preliminary FY 2018 IMD DSH limits published
in the July 6, 2018 Federal Register (83 FR 31536). Since the final FY
2018 DSH allotments were less than the preliminary FY 2018 DSH
allotments, the associated FY 2018 IMD DSH limits also decreased.
The final FY 2019 DSH allotments being published in this notice are
$36 million less than the preliminary FY 2019 DSH allotments published
in the February 11, 2019 Federal Register (84 FR 3169). The decrease in
the final FY 2019 DSH allotments is a result of being calculated by
multiplying the actual increase in the CPI-U for 2018 by the final FY
2018 DSH allotments, while the preliminary FY 2019 DSH allotments were
calculated by multiplying the estimated CPI-U for 2018 by the
preliminary FY 2018 DSH allotments. Although the estimated and actual
increase in the CPI-U remained the same at 2.4 percent, the preliminary
FY 2018 DSH allotments were higher than the final FY 2018 DSH
allotments and therefore the final FY 2019 DSH allotments are lower
than the preliminary FY 2019 DSH allotments. The final FY 2019 IMD DSH
limits being published in this notice are approximately $2 million
lower than the preliminary FY 2019 IMD DSH limits published in the
February 11, 2019 Federal Register (84 FR 3169). The decreases in the
IMD DSH limits are because the DSH allotment for a FY is a factor in
the determination of the IMD DSH limit for the FY. Since the final FY
2019 DSH allotments were decreased as compared to the preliminary FY
2019 DSH allotments, the associated FY 2019 IMD DSH limits for some
States were also decreased. This is a result of statutory provision,
discussed above, that the aggregate limit for DSH payments to IMDs and
other mental health facilities is the lesser of a State's FY 1995 total
computable IMD and other mental health facility DSH expenditures
applicable to the State's FY 1995 DSH allotment or the amount equal to
the product of the State's current year total computable DSH allotment
and the applicable percentage specified in section 1923(h) of the Act.
As a result of the final FY 2019 DSH allotments decreasing from the
preliminary FY 2019 DSH allotments, States that had applicable
percentages of their current year's total computable DSH allotments
lower than FY 1995 total computable IMD and other mental health
facility DSH expenditures had their IMD limits decreased as a result.
The preliminary FY 2020 DSH allotments being published in this
notice have been increased by approximately $1.6 billion more than the
preliminary FY 2019 DSH allotments published in the February 11, 2019
Federal Register (84 FR 3169). The increase in the DSH allotments is
due to the application of the statutory formula for calculating DSH
allotments under which the prior fiscal year allotments are increased
by the percentage increase in the CPI-U for the prior fiscal year, and
to the ARP adjustment, as discussed in more detail in the next
paragraph. The preliminary FY 2020 IMD DSH limits being published in
this notice are approximately $246 million more than the preliminary FY
2019 IMD DSH limits published in the February 11, 2019 Federal Register
(84 FR 3169). The increases in the IMD DSH limits are because the DSH
allotment for a FY is a factor in the determination of the IMD DSH
limit for the FY. Since the preliminary FY 2020 DSH allotments are
greater than the preliminary FY 2019 DSH allotments, the associated
preliminary FY 2020 IMD DSH limits for some States also increased.
The preliminary FY 2020 DSH allotments (before application of the
ARP adjustment) being published in this in this notice are
approximately $238 million more than the final FY 2019 DSH allotments
being published in this notice. This increase is attributable to the
application of the statutory formula for calculating DSH allotments
under which the prior fiscal year allotments are increased by the
percentage increase in the CPI-U for the prior fiscal year. The
applicable historical percentage change in the CPI-U for FY 2019 was
1.9 percent. The preliminary FY 2020 DSH allotments were further
increased by approximately $1.4 billion in order to comply with the
statutory provisions of the ARP requiring us to recalculate FS DSH
allotments to an amount that will allow States to make the same amount
of TC DSH payments as they would have been otherwise able to make in
the absence of the FFCRA FMAP increase.
The preliminary FY 2021 DSH allotments (before application of the
ARP adjustment) being published in this notice are approximately $192
million more than the preliminary FY 2020 DSH allotments published in
this notice. The increase in the DSH allotments is due to the
application of the statutory formula for calculating DSH allotments
under which the prior fiscal year allotments are increased by the
percentage increase in the CPI-U for the prior fiscal year. The
applicable historical percentage change in the CPI-U for FY 2020 was
1.5 percent. The preliminary FY 2020 DSH allotments were increased by
approximately $1.4 billion in order to comply with the statutory
provisions of the ARP requiring us to recalculate FS DSH allotments to
an amount that will allow States to make the same amount of TC DSH
payments as they would have been otherwise able to make in the absence
of the FFCRA FMAP increase. The preliminary FY 2021 DSH allotments were
further increased by approximately $1.4 billion in order to comply with
the statutory provisions of the ARP requiring us to recalculate FS DSH
allotments to an amount that will allow States to make the same amount
of TC DSH payments as they would have been otherwise able to make in
the absence of the FFCRA FMAP increase.
[[Page 14862]]
The preliminary FY 2021 IMD DSH limits being published in this
notice are approximately $16 million more than the preliminary FY 2020
IMD DSH limits published in this notice. The increases in the IMD DSH
limits are because the DSH allotment for a FY is a factor in the
determination of the IMD DSH limit for the FY. Since the preliminary FY
2021 DSH allotments are greater than the preliminary FY 2020 DSH
allotments, the associated preliminary FY 2021 IMD DSH limits for some
States also increased.
The RFA requires agencies to analyze options for regulatory relief
of small businesses, if a rule has a significant impact on a
substantial number of small entities. For purposes of the RFA, small
entities include small businesses, nonprofit organizations, and small
governmental jurisdictions. Most hospitals and most other providers and
suppliers are small entities, either by nonprofit status or by having
revenues of less than $8.0 million to $41.5 million in any one year.
Individuals and States are not included in the definition of a small
entity. We are not preparing an analysis for the RFA because the
Secretary has determined that this notice will not have significant
economic impact on a substantial number of small entities.
Specifically, any impact on providers is due to the effect of the
various controlling statutes; providers are not impacted as a result of
the independent regulatory action in publishing this notice. The
purpose of the notice is to announce the latest DSH allotments and IMD
DSH limits, as required by the statute.
In addition, section 1102(b) of the Act requires us to prepare a
regulatory impact analysis if a rule may have a significant impact on
the operations of a substantial number of small rural hospitals. This
analysis must conform to the provisions of section 604 of the RFA. For
purposes of section 1102(b) of the Act, we define a small rural
hospital as a hospital that is located outside of a Core-Based
Statistical Area for Medicaid payment regulations and has fewer than
100 beds. We are not preparing analysis for section 1102(b) of the Act
because the Secretary has determined that this notice will not have a
significant impact on the operations of a substantial number of small
rural hospitals.
The Medicaid statute specifies the methodology for determining the
amounts of States' DSH allotments and IMD DSH limits; and as described
previously, the application of the methodology specified in statute
results in the decreases or increases in States' DSH allotments and IMD
DSH limits for the applicable FYs. The statute applicable to these
allotments and limits does not apply to the determination of the
amounts of DSH payments made to specific DSH hospitals; rather, these
allotments and limits represent an overall limit on the total of such
DSH payments. For this reason, we do not believe that this notice will
have a significant economic impact on a substantial number of small
entities.
Section 202 of the Unfunded Mandates Reform Act of 1995 also
requires that agencies assess anticipated costs and benefits before
issuing any rule whose mandates require spending in any 1 year of $100
million in 1995 dollars, updated annually for inflation. In 2021, that
threshold is approximately $158 million. This notice will have no
consequential effect on spending by State, local, or tribal
governments, in the aggregate, or on the private sector.
Executive Order 13132 establishes certain requirements that an
agency must meet when it issues a proposed rule (and subsequent final
rule) that imposes substantial direct requirement costs on State and
local governments, preempts State law, or otherwise has Federalism
implications. Since this notice does not impose any costs on State or
local governments or otherwise have Federalism implications, the
requirements of E.O. 13132 are not applicable.
A. Alternatives Considered
Because the FFCRA temporary FMAP increase of 6.2 percentage points
was not applicable to the 1st quarter of FY 2020, we considered
utilizing prorated FMAP rates in the calculation of the ARP-adjusted FY
2020 DSH allotments. However, this could have been contrary to the
statutory language at section 1923(f)(3)(F) of the Act requiring us to
recalculate FS DSH allotments to an amount to allow for States to make
the same amount of TC DSH payments as they would have been otherwise
able to make in the absence of the FFCRA FMAP increase, depending on
States' timing of their DSH payments to eligible providers. The
methodologies for determining the States' fiscal year DSH allotments
and IMD DSH limits, as reflected in this notice, were established in
accordance with the methodologies and formula for determining States'
allotments and limits as specified in statute. This notice does not put
forward any further discretionary administrative policies for
determining such allotments and limits, or otherwise.
B. Accounting Statement
As required by OMB Circular A-4 (available at https://obamawhitehouse.archives.gov/omb/circulars_a004_a-4/), in Tables 1 and
2, we have prepared an accounting statement showing the classification
of the estimated expenditures associated with the provisions of this
notice. Table 1 provides our best estimate of the change (decrease) in
the FS of States' Medicaid DSH payments resulting from the application
of the provisions of the Medicaid statute relating to the calculation
of States' FY DSH allotments and the increase in the FY DSH allotments
from FY 2019 to FY 2020. Table 2 provides our best estimate of the
change (decrease) in the FS of States' Medicaid DSH payments resulting
from the application of the provisions of the Medicaid statute relating
to the calculation of States' FY DSH allotments and the increase in the
FY DSH allotments from FY 2020 to FY 2021.
Table 1--Accounting Statement: Classification of Estimated Expenditures,
From the FY 2019 to FY 2020
[In millions]
------------------------------------------------------------------------
Category Transfers
------------------------------------------------------------------------
Annualized Monetized Transfers............ $238.
From Whom To Whom? Federal Government to
States.
------------------------------------------------------------------------
Table 2--Accounting Statement: Classification of Estimated Expenditures,
From the FY 2020 to FY 2021
[In millions]
------------------------------------------------------------------------
Category Transfers
------------------------------------------------------------------------
Annualized Monetized Transfers............ $192.
From Whom To Whom? Federal Government to
States.
------------------------------------------------------------------------
C. Congressional Review Act
This document is subject to the Congressional Review Act provisions
of the Small Business Regulatory Enforcement Fairness Act of 1996 (5
U.S.C. 801 et seq.) and has been transmitted to the Congress and the
Comptroller General for review.
[[Page 14863]]
In accordance with the provisions of Executive Order 12866, this
notice was reviewed by the Office of Management and Budget.
Chiquita Brooks-LaSure, Administrator of the Centers for Medicare &
Medicaid Services, approved this document on February 1, 2022.
Dated: March 9, 2022.
Xavier Becerra,
Secretary, Department of Health and Human Services.
BILLING CODE 4120-01-P
[[Page 14864]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.006
[[Page 14865]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.007
[[Page 14866]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.008
[[Page 14867]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.009
[[Page 14868]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.010
[[Page 14869]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.011
[[Page 14870]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.012
[[Page 14871]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.013
[[Page 14872]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.014
[[Page 14873]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.016
[[Page 14874]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.017
[[Page 14875]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.018
[[Page 14876]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.020
[[Page 14877]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.021
[[Page 14878]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.022
[[Page 14879]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.023
[[Page 14880]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.024
[[Page 14881]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.025
[[Page 14882]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.026
[[Page 14883]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.027
[[Page 14884]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.028
[[Page 14885]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.029
[[Page 14886]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.030
[[Page 14887]]
[GRAPHIC] [TIFF OMITTED] TN16MR22.031
[[Page 14888]]
[FR Doc. 2022-05459 Filed 3-14-22; 4:15 pm]
BILLING CODE 4120-01-C